Bath & Body Works Surges on Stock Recommendation; Klarna Drops on Guidance

Source Summary

Klarna shares fell in premarket trading after the payments company reported full-year revenue and gross merchandise value guidance that missed expectations, citing foreign exchange pressures and volumes in Germany, despite reporting a profit beat for the second consecutive quarter. Amylyx Pharmaceuticals shares rallied as much as 54% after the drug developer reported that a late-stage trial of its experimental drug met its primary endpoint as a treatment for low blood sugar levels following bariatric surgery. Bath & Body Works shares surged after Citi raised its recommendation to buy from neutral, with analyst Paul Lejuez citing a favorable risk/reward outlook; the company is scheduled to release earnings next week.